2025
Race Comparisons in Patients With Cardiac Sarcoidosis: Insights From the Cardiac Sarcoidosis Consortium.
Trongtorsak A, De La Rosa Martinez J, Crawford T, Bogun F, Gu X, Purroll E, Ellenbogen K, Chicos A, Roukoz H, Zimetbaum P, Kalbfleisch S, Murgatroyd F, Steckman D, Rosenfeld L, Soejima K, Bhan A, Vedantham V, Dickfeld T, De Lurgio D, Platonov P, Zipse M, Nishiuchi S, Ortman M, Narasimhan C, Patton K, Rosenthal D, Mukerji S, Hoogendoorn J, Zeppenfeld K, Torosoff M, Judson M, Martin K, Madias C, Hermel M, Nour K, Torbey E, Sauer W, Kron J. Race Comparisons in Patients With Cardiac Sarcoidosis: Insights From the Cardiac Sarcoidosis Consortium. Circulation Arrhythmia And Electrophysiology 2025, e013670. PMID: 40557494, DOI: 10.1161/circep.124.013670.Peer-Reviewed Original ResearchLeft ventricular ejection fractionCardiac sarcoidosisVentricular ejection fractionBlack patientsEjection fractionNo significant differenceClinical outcomesPrimary outcomeWhite patientsImplantable cardioverter defibrillator therapyLeft ventricular assist device implantationSignificant differenceVentricular assist device implantationComposite end pointChronic kidney diseaseChronic obstructive pulmonary diseaseAll-Cause MortalityAssist device implantationRates of lungRates of hypertensionObstructive pulmonary diseaseImplantable cardioverter defibrillatorExtracardiac involvementEye involvementHeart transplantation
2019
Evolving patterns of metastatic renal cell carcinoma: A meta-analysis.
Lin J, Oh W, Liaw B, Galsky M, Tsao C. Evolving patterns of metastatic renal cell carcinoma: A meta-analysis. Journal Of Clinical Oncology 2019, 37: 563-563. DOI: 10.1200/jco.2019.37.7_suppl.563.Peer-Reviewed Original ResearchMetastatic renal cell carcinomaRate of bone metastasesPattern of metastasisBone metastasesClinical trialsRate of lymph node metastasisPattern of metastatic diseaseFirst-line therapyLymph node metastasisRenal cell carcinomaClinical trial patientsTherapeutic clinical trialsRates of lungReport metastasisMetastatic diseaseSecond-lineLiver metastasesCell carcinomaFirst-lineNode metastasisTreatment eraBaseline characteristicsTreatment modalitiesEvaluate temporal trendsTrial patients
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply